TONIX PHARMACEUTICALS HOLDING CORP. 8-K

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm 

We consent to the incorporation by reference in the registration statement (No. 333-254975) on Form S-3 of Tonix Pharmaceuticals Holding Corp. of our report dated July 18, 2023, with respect to the abbreviated financial statements of the Tosymra® and Zembrace® Symtouch® Product Lines of Upsher-Smith Laboratories, LLC, not included herein, which report appears in the Form 8-K/A dated July 18, 2023 of Tonix Pharmaceuticals Holding Corp. and to the references to our firm under the heading of “Experts” in the prospectus supplement contained in such registration statement.

Minneapolis, Minnesota

July 25, 2023